Solana ETF 获批前景:从「几乎无望」到「2025 年底前可期」,当前有哪些挑战?

Daiwa SMBC Capital

investment firm

About

Daiwa SMBC Capital is a venture capital firm that finances later stage and private equity investments.

  • Tokyo,Tokyo,Japan

Details

Operating Status
Active
Also Known As
大和SMBCキャピタル
Investor Type
Venture Capital

Daiwa SMBC Capital is a venture capital firm based in Tokyo that finances later stage and private equity investments.

Investments

Number of Investments
Number of Lead Investments
7
2
Daiwa SMBC Capital has made 7 investments. Their most recent investment was on Feb 1, 2012, when REGiMMUNE raised $5M.
Date Company Name
Round Money Raised Industry Lead Investor
Feb 1, 2012 REGiMMUNE
Series C $5M Biopharma Yes
Series Unknown ¥507.90M Biopharma
Oct 15, 2008 100e.com
Series B $8M Cloud Computing Yes
May 15, 2007 NexWave Solutions
Series C $5M Consumer Electronics
Series C $46.50M Embedded Software

Employee Profiles

Number of Employee Profiles
1
Daiwa SMBC Capital has 1 current employee profiles, including Executive Kawasaki Kenichi
Executive

Exits

Daiwa SMBC Capital has had 3 exits. Daiwa SMBC Capital most notable exits include FibroGen ,   Gene Techno Science

Date Company Name Exit Type Industry
Nov 21, 2014 FibroGen IPO Biopharma Detail
Nov 30, 2012 Gene Techno Science M&A Biopharma Detail
May 17, 2011 SiGe Semiconductor M&A Consumer Electronics Detail